whitepaper

Application note: Fast track antibody discovery

Posted: 7 March 2019 | | No comments yet

Learn more about an emerging high-throughput method for identifying and isolating rare cells secreting antigen-specific antibodies.

Antibody-derived biologics have become a major class of modern medicine, particularly in the fight against cancer and autoimmune diseases. Highly efficacious immunoglobulin-based drugs have been developed naturally via the antibody-producing B cells of the mammalian immune system, although finding rare cells with the right characteristics has always been challenging.

Please complete the form below in order to download this application note:











To read this Application Note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: Sphere Fluidics Ltd

Related organisations

Send this to a friend